Use of a Hu-SCID mouse model to develop and test candidate TB Vaccines.

被引：0
|
作者：
Terzioglu, E [1 ]
Sandhu, J [1 ]
Harkness, R [1 ]
Dunn, P [1 ]
Gorczynski, RM [1 ]
机构：
[1] Toronto Hosp, Toronto, ON M5T 2S8, Canada
来源：
FASEB JOURNAL | 1999年 / 13卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A635 / A635
页数：1
相关论文
共 50 条
  • [21] Development of vaccines and passive immunotherapy against SARS coronavirus using mouse and SCID-PBL/hu mouse models
    Okada, Masaji
    Takemoto, Yuji
    Okuno, Yoshinobu
    Hashimoto, Satomi
    Fukunaga, Yukari
    Tanaka, Takao
    Kita, Yoko
    Kuwayama, Sechiko
    Muraki, Yumiko
    Kanamaru, Noriko
    Takai, Hiroko
    Okada, Chika
    Sakaguchi, Yayoi
    Furukawa, Izumi
    Yamada, Kyoko
    Izumiya, Miwa
    Yoshida, Shigeto
    Matsumoto, Makoto
    Kase, Tetsuo
    Peiris, J. S. M.
    deMello, Daphne E.
    Chen, Pei-Jer
    Yamamoto, Naoki
    Yoshinaka, Yoshiyuki
    Nomura, Tatsuji
    Ishida, Isao
    Morikawa, Shigeru
    Tashiro, Masato
    Sakatani, Mitsunori
    NIDOVIRUSES: TOWARD CONTROL OF SARS AND OTHER NIDOVIRUS DISEASES, 2006, 581 : 561 - 566
  • [22] Establishment of the hu-PBL-SCID mouse model for the investigation of thyroid cancer
    Gyory, F
    Mezosi, E
    Szakall, S
    Bajnok, L
    Varga, E
    Borbely, A
    Gazdag, A
    Juhasz, I
    Lukacs, G
    Nagy, EV
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2005, 113 (07) : 359 - 364
  • [23] The development of DNA vaccines and passive immunotherapy against SARS coronavirus using mouse and SCID-PBL/hu mouse models
    Okada, M
    Takemoto, Y
    Okuno, Y
    Hashimoto, S
    Fukunaga, Y
    Tanaka, T
    Kita, Y
    Kuwayama, S
    Muraki, Y
    Kanamaru, N
    Takai, H
    Okada, C
    Sakaguchi, Y
    Furukawa, I
    Yamada, K
    Izumiya, M
    Yoshida, S
    Matsumoto, M
    Kase, T
    Peiris, M
    Ishida, I
    Morikawa, S
    Tashiro, M
    Sakatani, M
    FASEB JOURNAL, 2005, 19 (04): : A895 - A895
  • [24] Dectins - Use of dectin-2 promoter to develop Langerhans cell-targeted genetic vaccines.
    Morita, A
    Ariizumi, K
    Jester, JV
    Johnston, SA
    Takashima, A
    JOURNAL OF LEUKOCYTE BIOLOGY, 1998, : 13 - 13
  • [25] Gene therapy approaches for AIDS: Use of pseudotyped retroviral vectors and toxin genes in SCID-hu mouse model
    Akkina, RK
    Banda, NK
    Gorantla, S
    Bai, J
    Harrison, GS
    ADVANCES IN ANIMAL VIROLOGY, 2000, : 397 - 405
  • [26] A SCID-hu in vivo mouse model of human primary mantle cell lymphoma
    Wang, Michael
    Shi, Yuankai
    Zhang, Liang
    Han, Xiaohong
    Yang, Jing
    Qian, Jianfei
    Hong, Sungyoul
    Lin, Pei
    Romaguera, Jorge
    Kwak, Larry W.
    Yi, Qing
    BLOOD, 2007, 110 (11) : 691A - 691A
  • [27] The SCID-hu mouse: An in vivo model for HIV-1 infection in humans
    Bonyhadi, ML
    Kaneshima, H
    MOLECULAR MEDICINE TODAY, 1997, 3 (06): : 246 - 253
  • [28] EVALUATION OF GP160 VACCINEES IN THE HU-PBL-SCID MOUSE MODEL
    MOSIER, DE
    GULIZIA, RJ
    MACISAAC, P
    MATHIESON, BJ
    SMITH, G
    HU, SL
    COREY, L
    GREENBERG, P
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (08) : 1387 - 1387
  • [29] SCID-HU MOUSE AS A MODEL FOR HUMAN LUNG HIV-1 INFECTION
    CESBRON, JY
    AGUT, H
    GOSSELIN, B
    CANDOTTI, D
    RAPHAEL, M
    PUECH, F
    GRANDADAM, M
    DEBRE, P
    CAPRON, A
    AUTRAN, B
    COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE III-SCIENCES DE LA VIE-LIFE SCIENCES, 1994, 317 (07): : 669 - 674
  • [30] THE SCID-HU MOUSE - A SMALL ANIMAL-MODEL FOR HIV-INFECTION
    MCCUNE, JM
    RABIN, L
    KANESHIMA, H
    NAMIKAWA, R
    SHIH, CC
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (02) : 212 - 213
12345